NEXT NALOXONE: S AVING LIVES WITH NALOXONE
As the U.S. faces a growing overdose crisis, the mission of NEXT Naloxone is simple: save lives, by getting naloxone into the hands of people who need it the most.
WHAT WE DO NEXT Naloxone provides overdose prevention education and distributes naloxone to people at risk of overdose - or who know someone at risk - and have no other way to access the medication.
THE NEED When a person overdoses from opioids, there is a small window of opportunity to reverse the overdose and ensure the person stays alive. Naloxone (brand name Narcan) is an FDA-approved medication proven to reduce opioid overdose deaths.1,2 Despite overwhelming evidence that common laypersons can safely and effectively administer the life-saving medication, thousands of Americans still have no access to naloxone. 65% of NEXT Naloxone recipients have nowhere to access naloxone locally, while 15% can’t afford it even if it is available locally.
“When I asked the local pharmacy, I was told my city didn't have Narcan.”
“I live in a small town and no insurance makes the medicine cost $250 out of pocket.”
- NEXT Naloxone recipients
IMPACT Launched in 2018, NEXT Naloxone has distributed over 3,500 naloxone kits, preventing 244 overdose deaths in 35 states, to-date.3 Over 80% of people who responded to an overdose using the naloxone sent to them did so within three months of receiving their kit. NEXT Naloxone reaches people most in need of naloxone: 84% of our recipients have never received naloxone before. 71% either personally experienced and/or witnessed an overdose. For 72%, the overdose response training on the NEXT Naloxone site was the first training they’ve ever completed.
NEXT Naloxone has reached people in 50 states, but especially those with the highest burden of overdose deaths. Number of overdose deaths by state, 2017
Number of NEXT Naloxone requests fulfilled by state, 2017-2019
1
US Department of Health and Human Services. (2018). Surgeon general's advisory on naloxone and opioid overdose. Online document at: www. surgeongeneral. gov/priorities/opioidoverdose-prevention/naloxone-advisory. html Accessed April, 6. 2 Abouk, R., Pacula, R. L., & Powell, D. (2019). Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose. JAMA Internal Medicine. 3 Number of overdose reversals likely underreported